Download PowerPoint - New Page 1

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Cardiovascular disease wikipedia , lookup

Management of acute coronary syndrome wikipedia , lookup

Cardiac contractility modulation wikipedia , lookup

Electrocardiography wikipedia , lookup

Lutembacher's syndrome wikipedia , lookup

Coronary artery disease wikipedia , lookup

Jatene procedure wikipedia , lookup

Mitral insufficiency wikipedia , lookup

Hypertrophic cardiomyopathy wikipedia , lookup

Heart failure wikipedia , lookup

Cardiac surgery wikipedia , lookup

Arrhythmogenic right ventricular dysplasia wikipedia , lookup

Antihypertensive drug wikipedia , lookup

Dextro-Transposition of the great arteries wikipedia , lookup

Quantium Medical Cardiac Output wikipedia , lookup

Transcript
Pathophysiology of Brain & Body
USSJJQ-20-3
Heart Failure
Introduction

Heart function…




pump sufficient blood to organs to…
furnish oxygen/substrates and remove metabolites…
thereby maintaining ‘steady-state’ (homeostasis)
Heart failure (HF)



ventricular contraction compromised such that...
heart cannot meet demand or…
can only do so at raised ventricular pressure



Increased workload & reduced cardiac reserve
A symptom complex rather than a single disease
Types


Chronic - eg congestive heart failure (CHF)
Acute - eg myocardial infarct

not usually classed as heart failure (different ICD code to HF)
CHF Incidence (USA)

~ 5.3 million people in the USA (2006)




estimated that similar number have unsuspected HF


Circa 2% of the population has HF
75-80% of these > 65 years of age
Approx 660,000 new cases each year
likely to develop symptoms in the next 1-5 years
HF  3 million visits to the doctor  1 million
hospitalisations per year (2009)
CHF Burden (USA)




Approx 57,000 deaths in 2009
A leading cause of hospitalisation for > 65 years old
The risk of death is 5 - 10% per year (mild symptoms),
30-40% (severe symptoms)
$25-40 billion on care of HF patients




$8-15 billion on hospitalisations
~ $10,000 per admission (~1,000,000 admissions in 2005)
rest in medications, home health care, etc
does not include indirect costs (eg lost productivity)
Incidence of heart failure, by sex and age, 1995/96, Hillingdon
Cowie MR et al (1999) European Heart Journal 20: 421-428
Heart Failure

Common, Deadly, Expensive, ‘Epidemic’

Risk Factors








Coronary Artery Disease, previous MI
Hypertension
Obesity
Diabetes, Dyslipidemia
Valvular disease; eg aortic valve stenosis
Drug/disease-induced myocardial dysfunction
Smoking
Congenital defects
Cardiac Output (CO) and Cardiac Reserve


CO is the volume pumped per ventricle per min
CO = heart rate (HR) x stroke volume (SV)




Cardiac reserve is the difference between
resting and maximal CO (5 L/min vs 30 L/min)
Eg CO (ml/min) = HR (75 beats/min) x SV (70
ml/beat)


HR is the number of beats per minute
SV is the volume of blood pumped out by a ventricle
with each beat (SV = EDV – ESV)
= 5250 ml/min or 5.25 L/min
Low CO in HF essentially a problem with SV
CO = HR x SV : Control of Stroke Volume

Preload – amount ventricles are stretched prior
to systole


Contractility – cardiac cell contractile force due
to factors other than EDV


set by End Diastolic Volume
Eg circulating epinephrine
Afterload – back pressure exerted by blood in
the large arteries leaving the heart

Ie pressure against which ventricle is ‘pushing’
SV and Preload : Starling’s Law of the Heart
 The heart is a ‘demand
pump’
 It always attempts to
pump what returns to it
(Venous Return)
 Greater VR 
greater filling 
greater stretch 
greater force 
greater stroke vol 
greater CO
 Starling’s Law of the Heart
SV and Preload: Starling’s Law of the Heart
SV and Afterload
 Before it can actually pump
blood, the ventricle must
expend energy generating
a pressure > arterial
pressure
 ie > diastolic pressure
 Some of the work done by
the heart muscle is ‘wasted’
by not pumping blood
 during isolvolumetric
contraction
SV and Contractility

Contractility is a change in contractile
strength independent of stretch/EDV


↑ contractility  ↑ Stroke Volume
↑ in contractility comes from:
↑ sympathetic activity
 Hormones such as epinephrine
++ and some drugs
 Ca

Law of Laplace: the physics of failure

Wall tension in ventricle
reflects the minimum work the muscle must perform to just
shorten
T = P x r / 2H





T = tension
P = pressure
r = radius
H = wall thickness
Can rearrange  P

Raised preload



= T x 2H
r
overfilling ventricles ↓ H, ↑ r
so ↑ T needed to generate same P needed to eject blood
Raised afterload


↑ P needed to eject blood
So ↑ T needs to be produced, all other things equal
Categories of Heart Failure








Chronic (CHF)
Acute (MI)
High output
Low output
Systolic
Diastolic
Right-side
Left-side
High/Low Output

High output
Rare
 Excessive need for CO, even at rest
 Causes do not reflect inadequate heart

Severe anaemia
 Hyperthyroidism
 Arteriovenous shunts (low resistance pathways)


Low output
Most common
 Impaired pumping ability


Eg ischaemic heart disease
Systolic



Impaired ejection during systole
↓ in contractility & ejection fraction
Typical causes…

Ischaemic Heart Disease (2/3rds of Sys HF),
cardiomyopathy


Hypertension, valvular (eg aortic) stenosis


Affect contractile activity
Cause pressure overload in ventricle
Results in ↓ ejection fraction


Can be as low as 15% (normally 65%)
Causes ↑ in EDV, dilation, pressure

Law of Laplace means this is not good! 
Diastolic

Impaired filling during diastole


Leads to congestive symptoms
Caused by…

Myocardial hypertrophy (eg caused by hypertension)


↑ ventricular wall thickness
Ischaemic Heart Disease

Delayed ventricular relaxation


Mitral valve stenosis


↓ O2 so ↓ ATP (needed to pump Ca++ and break actomyosin)
Poor ventricular filling
Features



Ventricular hypertrophy  abnormal remodelling
↓ chamber size
↓ventricular compliance

‘stiffer’ chambers more difficult to fill
Right-sided


Impaired pumping of blood to lungs
Leads to…
Damming of blood in systemic veins
 ↑ in systemic venous, r. atrial, r. vent. ED
pressures
 Fluid movement to interstitial spaces



Oedema, especially lower regions
Backup in liver and portal vessels →
Impaired liver function
 Impaired digestion
 Ascites


Weight gain through fluid retention
Left-sided


Impaired pumping of blood to systemic
circ.
Leads to…
Damming of blood in pulmonary vessels
 ↑ in pulmonary, L. atrial, L. vent. ED
pressures
 Fluid movement to pulmonary interstitium

Impaired gas exchange
 Cyanosis, shortness of breath



Oedema

Symptoms
Due to ↑venous/capillary pressure

‘damming’ of blood and salt/water retention
Nocturia

Return of fluid from interstitial spaces in tissues to
plasma when supine

Dyspnea (shortness of breath): cardinal sign

↑ diffusion distance due to pulmonary oedema
 Worse when lying down (↑ VR  pulm congestion)
 Especially at night (paroxsymal nocturnal dyspnea)
 Bronchospasm due to excess fluid (cardiac asthma)
Above arise from altered microcirculation fluid dynamics

Cyanosis



Bluish mucosal membranes/skin
↓ oxygenation in lungs + ↑ extraction in tissues
Physiological Response to HF

Response to ↓ SV & ↓ CO

↑ Sympathetic tone and (nor)epinephrine



↑ heart rate and contractility
NE/E can ↑ TPR and, therefore, afterload
Na+ & H2O retention


Via activation of RAS by ↓ RBF & ↓ BP
↑ SV by ↑ ventricular filling (Frank-Starling mechanism)


Frank Starling mechanism


CO can be normal at rest due to ↑ ED V & P
Exercise-induced ↑ in CO at high ED V & P


Can be counter-productive by ↑ ‘volume load’ on heart
Can lead to pulmonary congestion/shortness of breath
Myocardial hypertrophy


Like skeletal muscle, cardiac response to exercise
Can get abnormal remodelling of chamber → ↓ volume
Compensated vs Decompensated

If physiological responses restore CO


Compensated 
If physiological responses fail to restore CO


Decompensated 
↑HR


↑TPR


↑ afterload
Na+ & H2O retention



↓ diastolic filling time
Over-stretching of ventricles
Development of oedema
Further responses exacerbate the situation
Therapeutics


Diuretics
Beta-adrenergic blockers


Vasodilators


Captopril, Enalopril
Angiotensin II receptor antagonists


Nitrates (eg nitroglycerin)
ACE inhibitors


Carvedilol
Losartan
Positive inotropic drugs



Cardiac glycosides
Sympathomemetics
Phosphodiesterase inhibitors
Cardiac Contraction








Only 10% of myocardial cell volume is
cytoplasm
Na + channels open for 1-2 msec
Slow Ca++ channels open and conc ↑
Contractile protein activation occurs
K+ channels open and K+ efflux restores RMP
Ca++ channels close
Ca++ conc returned to normal by Ca++ pumps
May wish to bolster contraction short-term but ‘unload’
heart long-term – a therapeutic tightrope!
Possible Interventions

↑ Na+ influx


↑ Ca++ loading of the SR


Maintain Ca++ concentration
Inhibit K+ channels


Greater Ca++ release
↓ Ca+ extrusion


Larger depolarisation
Prolong depolarisation
↓ adrenergic stimulation

‘unload’ the heart  recovery
Digitalis Glycosides



Extracted from the foxglove plant
Effective range = 1.0 - 2.5 ng/ml
But toxic range = 1.5 ng/ml and up !



↑ cytoplasmic Na+ conc
Inhibits Na+, K+-ATPase (sodium pump)




arrhythmias
↓ gradient inhibits Na+ influx which is…
coupled to Ca++ efflux so…
increases Ca++ retention & loading in the SR
Relieves symptoms, but does not ↑ survival
Diuretics: reversing renal retention


Drugs which ↑ Na+ & H2O excretion
↓ ECF volume, oedema


‘Unload’ ventricular filling
Normally, < 1% filtered Na+ /H2O excreted
Filtered load is circa 600 g/day & 180 L/day
 Topologically, filtrate is external to body
+
+
 Reabsorption of Na is active, via Na pump
 Reabsorption of H2O is passive, no H2O
pump

Relies on hydrostatic & osmotic forces
+
 By heart & Na pump

Common Diuretics Types

Loop diuretics


Thiazides


eg acetazolamide
Osmotic diuretics


eg bendrofluazide
Carbonic anhydrase inhibitors


eg frusemide
eg mannitol
K+ sparing

eg spironolactone
Loop diuretics


Eg: Frusemide/Furosemide
Most powerful diuretics


Affect up to 20% filtered Na+ load excreted
Mode of Action
Thick (ascending) segment of loop of Henle
 Inhibit Na/K/2Cl carrier via Cl-binding site


Misc

venodilator action seen clinically in the
treatment of heart failure

gives symptomatic relief occurring before the
onset of diuretic action
From Martinez-Maldonado, M, and Cordova, HR: Cellular and molecular aspects of the renal effects of diuretic
agents. Kidney Int. 1990, 38:632-641.
Loop Diuretics – unwanted effects


↑ Na+ conc reaching the distal tubule
Results in ↑ loss of H+ and K+
Exchangers are driven more
 Hypokalaemia




arrhythmias, convulsions
Metabolic alkalosis
Hypovolaemia

low cardiac output